Affordability, availability and tolerability of anti-seizure medications are better predictors of adherence than beliefs: Changing paradigms from a low resource setting

Epilepsy is one of the most common neurological disorders estimated to affect around 70 million people worldwide [1]. Anti-seizure medications (ASM) form the mainstay of treatment and help in achieving good seizure control in 70 % of patients with epilepsy (PWE). Medication non-adherence magnifies the morbidity and causes a threefold increase in mortality [2,3]. Medication adherence is defined as “the extent to which a person’s behaviour including taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider”.

0